The Clinicopathological features and survival outcomes of patients with different metastatic sites in stage IV breast cancer.
Wang R, Zhu Y, Liu X, Liao X, He J, Niu L. · 2019
Read The Clinicopathological features and survival outcomes of patients with different metastatic sites in stage IV breast cancer. by Wang R, Zhu Y, Liu X, Liao X, He J, Niu L. (2019) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc6852913.txt.
Description
Wang and co-authors report a study in BMC Cancer on stage IV breast cancer. At this stage the cancer has spread beyond the breast. Where it lands, in bone, lung, liver, or brain, may shape the illness. How features and survival differ by spread site was poorly understood.
The team drew cases diagnosed between 2010 and 2015 from the United States SEER registry. They compared tumour traits across single-site and multi-site spread. Survival was worst for brain spread and best for bone-only disease, with lung and liver in between. Surgery, radiation, and chemotherapy each linked to longer survival in the analysis. The authors say spread site should inform treatment planning.
Catalog record
| CREATOR | Wang R, Zhu Y, Liu X, Liao X, He J, Niu L. |
|---|---|
| YEAR | 2019 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 46 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |